Iqvia launches COVID-19 trial matching solutions
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S. read more.....»»
Trevena announces TRV027 selected by ACTIV initiative for COVID-19 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Moderna says trial booster vaccine effective against COVID-19 variants
Moderna Inc. stock rose more than 1% in the extended session Wednesday after the biotechnology company said that a single-dose booster COVID-19 vaccine worked against the novel coronavirus' variants, according .....»»
Moderna says trial booster vaccine effective against COVID-19 variants
Moderna Inc. stock rose more than 1% in the extended session Wednesday after the biotechnology company said that a single-dose booster COVID-19 vaccine worked against the novel coronavirus' variants, according .....»»
Humanigen reports publication of results from Phase 3 COVID-19 lenzilumab trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
We could find out if Pfizer"s COVID-19 vaccine works in kids aged 2 to 11 by September
Albert Bourla, Pfizer CEO, said that trial data for the youngest age-group, 6 months to two years, would be ready to show to the FDA by November. Trial data.....»»
Maui launches post-arrival Covid testing program for transpacific travelers
The program launched Tuesday in what officials say is a “soft opening” period. A full rollout is expected next week......»»
FDA to authorize the use of the Pfizer COVID-19 vaccine for those ages 12-15 as early as next week, The New York Times reports
Pfizer announced in late March that their vaccine was highly effective in a trial of more than 2,000 adolescents. vial.....»»
Vaxart slides after reporting delay of trial for potential COVID oral vaccine
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Precipio launches COVID-19 rapid antibody test on Amazon"s business platform
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novavax initiates pediatric expansion for Phase 3 trial of COVID-19 vaccine
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Innovation surpasses 50% enrollment in phase 2 trial of Brilacidin for COVID-19
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Numinus Launches Clinical Trial Of Naturally Derived Psilocybin
Numinus Wellness (Pink: LKYSF) (TSXV: NUMI) announced the launch of a new clinical trial that will add information to an industry insider debate: is read more.....»»
Investments in telehealth solutions in Portland address the need for members to continue essential care
The Covid-19 pandemic has changed the health care.....»»
Inovio stock plunges after U.S. government stops funding of Phase 3 trial of COVID-19 vaccine candidate
Shares of Inovio Pharmaceuticals Inc. plunged 29.7% toward a 13-month low, enough to pace all premar.....»»
A man who got his first COVID-19 vaccine a year ago in Moderna"s clinical trial just received his third shot - and he"s feeling great
The 30-year-old science communicator got his first shot of the Moderna vaccine in a clinical trial last April. He's since gotten two more shot.....»»
Inovio sinks 26% after US government decides to discontinue funding for next phase of COVID-19 vaccine trial
"The decision results from the changing environment of COVID-19 with the rapid deployment of vaccines," said Inovio in a st.....»»
NIH launches 3 new clinical trials studying COVID-19 treatments
The Nation.....»»
Dynavax: Valneva initiates Phase 3 trial for COVID-19 vaccine candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Trevena"s TRV027 selected for study in REMAP-CAP trial in COVID-19 patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»